Forte Biosciences, Inc. (FBRX)
Largest Insider Buys in Sector
FBRX Stock Price History Chart
FBRX Stock Performance
About Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Insider Activity of Forte Biosciences, Inc.
Over the last 12 months, insiders at Forte Biosciences, Inc. have bought $71,992 and sold $0 worth of Forte Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Forte Biosciences, Inc. have bought $184,562 and sold $4.45M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Wagner Paul A. (See Remarks) — $71,992.
The last purchase of 10,000 shares for transaction amount of $7,525 was made by Wagner Paul A. (See Remarks) on 2023‑12‑18.
List of Insider Buy and Sell Transactions, Forte Biosciences, Inc.
| 2023-12-18 | See Remarks | 10,000 0.0286% | $0.75 | $7,525 | -17.15% | |||
| 2023-12-14 | See Remarks | 10,000 0.0287% | $0.72 | $7,200 | -14.04% | |||
| 2023-12-13 | See Remarks | 10,520 0.0284% | $0.70 | $7,351 | -15.14% | |||
| 2023-12-12 | See Remarks | 4,776 0.013% | $0.65 | $3,088 | -9.19% | |||
| 2023-12-11 | See Remarks | 25,000 0.0719% | $0.65 | $16,188 | -2.43% | |||
| 2023-12-08 | See Remarks | 15,000 0.0406% | $0.62 | $9,300 | -2.03% | |||
| 2023-12-07 | See Remarks | 36,203 0.0971% | $0.58 | $21,168 | +3.45% | |||
| 2023-11-22 | See Remarks | 400 0.0011% | $0.43 | $172 | +37.30% | |||
| 2023-11-20 | See Remarks | 6,966 0.0175% | $0.44 | $3,048 | +21.00% | |||
| 2022-12-16 | See Remarks | 44,024 0.2759% | $1.07 | $47,000 | +2.04% | |||
| 2022-12-15 | See Remarks | 55,976 0.3253% | $1.03 | $57,672 | -1.96% | |||
| 2021-09-07 | Sale | See Remarks | 1M 7.2851% | $4.35 | $4.35M | -65.57% | ||
| 2021-09-07 | Sale | Chief Financial Officer | 25,000 0.1778% | $4.24 | $106,105 | -65.57% | ||
| 2020-06-29 | Chief Financial Officer | 2,000 0.0544% | $14.11 | $28,220 | +145.46% | |||
| 2020-06-26 | Chief Financial Officer | 4,700 0.1262% | $14.52 | $68,225 | +135.52% | |||
| 2020-06-25 | See Remarks | 7,000 0.1998% | $14.48 | $101,356 | +150.76% | |||
| 2020-04-14 | 10 percent owner | 74,301 0.1242% | $1.19 | $88,418 | +54.56% | |||
| 2020-03-02 | 10 percent owner | 65,149 0.0283% | $1.35 | $87,756 | -0.52% | |||
| 2019-05-30 | director | 43,000 0.0242% | $4.66 | $200,315 | -77.34% | |||
| 2019-05-28 | EVP & Chief Financial Officer | 5,000 0.0031% | $4.29 | $21,475 | -73.15% |
Insider Historical Profitability
| Wagner Paul A. | See Remarks | 1823236 124.7143% | $15.61 | 12 | 1 | +50.28% |
| Oliveira Steven Michael | 10 percent owner | 2873450 196.5518% | $15.61 | 2 | 0 | +27.02% |
| Hasnain Faheem | director | 245857 16.8173% | $15.61 | 2 | 0 | |
| FOLETTA MARK G | EVP & Chief Financial Officer | 15042 1.0289% | $15.61 | 2 | 0 | |
| SCHIMMEL PAUL | director | 13623 0.9319% | $15.61 | 1 | 0 |
Institutional Investor Ownership
| Tybourne Capital Management HK Ltd | $2.52M | 9.95 | 3.62M | 0% | +$0 | 0.43 | |
| Perceptive Advisors | $2.27M | 8.96 | 3.27M | 0% | +$0 | <0.01 | |
| Bvf Inc Il | $2.09M | 8.18 | 2.98M | 0% | +$0 | 0.02 | |
| Alger | $1.28M | 5.05 | 1.84M | 0% | +$0 | 0.01 | |
| Farallon Capital | $1.27M | 4.97 | 1.81M | 0% | +$0 | 0.01 |